Invesco Biotechnology & Genome ETF (PBE)
NYSEARCA: PBE · Real-Time Price · USD
78.79
-1.78 (-2.21%)
Mar 5, 2026, 4:00 PM EST - Market closed

PBE Holdings List

Mar 3, 2026
No.SymbolName WeightShares
1GILDGilead Sciences, Inc.6.21%106,606
2AMGNAmgen Inc.5.94%39,947
3UTHRUnited Therapeutics Corporation5.50%27,985
4BIIBBiogen Inc.5.48%75,525
5ILMNIllumina, Inc.5.41%106,022
6REGNRegeneron Pharmaceuticals, Inc.5.30%17,539
7INCYIncyte Corporation4.86%125,701
8FOLDAmicus Therapeutics, Inc.4.16%736,530
9ALNYAlnylam Pharmaceuticals, Inc.3.86%30,754
10BCRXBioCryst Pharmaceuticals, Inc.3.65%1,066,511
11RPRXRoyalty Pharma plc3.43%183,253
12BMRNBioMarin Pharmaceutical Inc.3.03%131,248
13PTGXProtagonist Therapeutics, Inc.2.99%83,070
14CPRXCatalyst Pharmaceuticals, Inc.2.92%309,839
15QGENQiagen N.V.2.90%154,469
16IONSIonis Pharmaceuticals, Inc.2.88%92,769
17EXELExelixis, Inc.2.77%172,410
18ACADACADIA Pharmaceuticals Inc.2.70%304,783
19HALOHalozyme Therapeutics, Inc.2.69%98,436
20NBIXNeurocrine Biosciences, Inc.2.67%51,571
21TGTXTG Therapeutics, Inc.2.59%227,421
22TECHBio-Techne Corporation2.58%114,731
23VCELVericel Corporation2.54%187,353
24COLLCollegium Pharmaceutical, Inc.2.52%159,830
25PTCTPTC Therapeutics, Inc.2.32%91,247
As of Mar 3, 2026